Promoter function for gene expression of the long terminal repeat (LTR) of human T-cell leukemia virus type I (HTLV-I) was studied by constructing plasmids containing the LTR sequence. The gene encoding chloramphenicol acetyltransferase 
The human T-cell leukemia virus type I (HTLV-I) (1-3) contains the extra sequence pX in its genome, in addition to gag, pol, and env which are required for the replication of the retroviruses in general (4) . The pX sequence (41.6 kilobases) contains four possible open reading frames (I-IV) but does not correspond to a typical retroviral onc gene derived from cellular sequences (4) .
We have recently identified the protein p40x, which is encoded by frame IV in the pX region (5) . The amino acid sequence specified by frame IV was found to be conserved up to 76% in HTLV-I and -II (6, 7) , strongly suggesting an indispensable function of p40x in viral replication or cellular transformation. Furthermore, the mechanism of the leukemogenesis in adult T-cell leukemia (ATL) was suspected to include a process mediated by a trans-acting viral function, since HTLV-I was identified as a causative agent in ATL development (8) (9) (10) , but no common site for the provirus integration was found in primary leukemic cells of ATL patients (11) . The pX-encoded protein, p40x, was considered the most likely candidate for the trans-acting viral function, because of its uniqueness to HTLV and its conservation in all HTLV-I isolates (12) .
HTLV-I is closely associated with ATL (2, 9, 13, 14) , which is a unique malignancy of a helper subset of T-cells (15) , and immortalizes T-lymphocytes in vitro (16, 17) . These observations indicate that HTLV-I is highly T-lymphotropic in its replication and cellular transformation. In animal retroviruses, the envelope glycoprotein defines the target specificity at the initial step of infection (18) , and the long terminal repeat (LTR) sequences are thought to be responsible for determining the tissue specificity for tumorigenicity (19) . In the HTLV-II system, Chen et al. (20) reported lymphoidspecific promoter activity in its LTR sequence. Therefore, it would be of interest to test the promoter function of the HTLV-I LTR, especially in relation to viral proteins.
In the work described here, we constructed plasmids consisting of HTLV-I LTR and a gene (CAT) encoding chloramphenicol acetyltransferase (CATase) and analyzed the promoter function by assaying CATase activity after transfection of cultured cells. The results showed that HTLV-I LTR can function very efficiently in HTLV-infected cells, even in cell lines expressing only the pX-encoded protein p40x, but not in HTLV-infected cells that do not express the viral antigens. These findings suggested that a factor in HTLV-transformed cells is activating the HTLV-I LTR in a trans-acting manner and that this factor could be p4QX. While these studies were being completed, Sodroski et al. (21) reported a trans-acting transcriptional activation of the HTLV LTR in HTLV-infected cells.
MATERIALS AND METHODS
Cells and Plasmids. The human cell line FL (22) was obtained from T. Taniguchi (Cancer Institute, Tokyo) and grown in McCoy's 5A medium containing 5% fetal calf serum. HTLV-infected human T-cell lines MT-1 (23), MT-2 (24), and HUT-102 (1) and HTLV-infected rat T-cell lines TARL-2, TARS-1, and TART-1, (25) were grown in RPMI 1640 medium containing 10% fetal calf serum. The rat cell lines were generously donated by T. Yoshiki (Hokkaido University, Japan). HOS, a human osteosarcoma cell line, and HTLV-infected HOS/MT-2 (21) were generously supplied by H. Hoshino (National Cancer Center, Japan). Plasmid pSV2-CAT (26) was obtained from B. Howard (National Cancer Institute, Bethesda, MD).
Transfection and CATase Assay. For transfection, the calcium phosphate coprecipitation method (27) was used for FL cells, and the DEAE-dextran method (28) was applied to lymphoid cell lines. FL cells (3 x 106) were seeded on 100-mm dishes; the next day, they were incubated for 4 hr at 37°C in growth medium containing 20 ,g of precipitated plasmid DNA. They were then exposed for 3 min to 30% (vol/vol) dimethyl sulfoxide in Tris-buffered saline (25 mM Tris Cl/137 mM NaCl/5 mM KCl/0.7 mM CaCI2/0.5 mM MgCl2/0.6 mM Na2HPO4, pH 7.5) at room temperature, washed with 10 ml of Tris-buffered saline, and incubated in growth medium for 40 hr.
For lymphoid cell lines, 2 x 106 cells were washed once with Tris-buffered saline and then suspended in 0. 6 (4) . A protein, p4OX, encoded by this pX sequence, has recently been identified by us (5) and others (29) (30) (31) . It was also found that the HTLVinfected rat T-cell lines TARL-2, TARS-1, and TART-1 produce p4Ox as almost the only detectable viral antigen (Fig. 3) .
Cell extracts of these three rat cell lines were analyzed by an immunoblotting procedure using antiserum to the synthetic decapeptide Ser-Glu-Lys-His-Phe-Arg-Glu-Thr-GluVal. This peptide corresponds to the carboxyl terminus of the protein predicted from the sequence of pX in reading frame IV (4). As shown in Fig. 3A, p4Ox was detected with the anti-peptide serum. This protein was identified previously as a protein encoded by pX reading frame IV (5). p4Ox was the main immuno-specific band, even with ATL patient serum (Fig. 3B) p19 and p24) and the env gene products (gp62, gp46 and p2OE) in MT-2 or HUT-102 cells (32, 33) . A few faint bands are seen in Fig. 3 ; however, these were concluded to be nonspecific bands, since these also were detected, although more faintly, in normal rat lymphocytes. Repeated experiments with other patient sera and antisera against env gene products did not detect any significant amount of viral protein other than p40x in the rat cell lines. Therefore, it was concluded that these rat cell lines express the pX protein p4Ox as the main viral protein and produce only trace amounts of gag and env gene products, if any. The pol gene product is not yet identified, but we expect that the pol gene, like the gag and env genes, is not highly expressed in rat cell lines. Our observations are slightly different from those of Tateno et al. (25) , who detected p24 in the rat cell line by metabolic labeling immunoprecipitation. Although the reason for this discrepancy is not known, it might be explained by alterations of cellular phenotypes after long passage in culture. Southern blot analysis of the rat cell line DNAs showed that at least one copy of a complete provirus of HTLV-I was integrated (unpublished data), but it is not known why the cells After pLTR-CAT transfection of TARL-2, TARS-i, and TART-1 cells, the CATase activity in the cells was 40 to 80 times higher than that seen after transfection with pSV2-CAT. The LTR activity was as strongly enhanced as in MT-2 and HUT-102 (Table 1, Fig. 2 ). pU3-CAT activity was also enhanced in the rat cell lines, although the stimulation was not high as for pLTR-CAT. These results strongly suggest that p40x is a trans-acting factor stimulating the promoter or enhancer function of the HTLV LTR and that the U3 sequence is responsible for this enhancement.
DISCUSSION
The LTR activity of HTLV-I in plasmid pLTR-CAT was markedly increased in lymphoid cell lines infected with HTLV-I and expressing HTLV proteins but was not increased in uninfected cells or in cells that do not express the HTLV proteins even when infected. The enhanced activity of the LTR also was observed in cells in which pX-encoded protein was the only viral protein detectable.
The correlation of the HTLV gene expression and the increased LTR activity strongly suggests that the HTLV genome codes for a factor that can stimulate the HTLV LTR function. However, one may argue that the factor stimulating the LTR function might be a cellular protein induced by transformation associated with HTLV infection or that perhaps a minor cell population that contains such a factor was selected and established a cell line after HTLV infection. It is hard to rule out these possibilities, but they seem unlikely since the LTR function was not increased in the HTLV-infected and -transformed T-cell line MT-1, which does not express HTLV efficiently. Other characteristics of MT-1 cells are very similar to those of other infected cell lines. More cell lines such as MT-1 and further characterization of the factor itself are necessary to reach a final conclusion. It is also possible that a virally encoded factor stabilizes the CATase mRNA, thus resulting in the increased CATase activity. However, in preliminary experiments, various deletions in the U3 sequence reduced the enhanced CATase activity in HITLV-producing cells but did not affect the basal activity in uninfected cells (unpublished results). These observations clearly indicated that mRNA stabilization cannot be the main factor causing the high CATase activity, since the CATase mRNA transcribed from all of these deletion mutants should have the same structure, although the U5 region may affect the result to some extent. Therefore, we suggest that a factor encoded by the HTLV-I genome stimulates the synthesis of mRNA from the LTR sequence rather than stabilizes the mRNA.
Yoshida and coworkers have reported previously that HTLV-I is an etiological agent of ATL (2) and that HTLV-I is directly involved in ATL leukemogenesis, based on analysis of 120 ATL patients who all had monoclonal tumor cells infected with HTLV (9, 10). HTLV-I also transforms or immortalizes T lymphocytes in vitro (16, 17, 24) . However, the mechanism of oncogenesis by HTLV is not known. HTLV-I does not contain a typical onc gene derived from cellular sequences (4) and does not seem to activate a cellular onc gene,-by insertional activation, because the proviral integration shows no common sites in cellular DNA of primary leukemic cells from 35 ATL patients tested (8, 11) . Consequently, a sequence of HTLV was suspected to encode a trans-acting factor, as with onc gene products. Such a sequence could be the pX region, first identified by sequence analysis (4), because all viral isolates of HTLV-I were found to retain the pX region (12) , and because the pX sequence was also conserved in the distantly related HTLV-II (6, 7). The pX sequence was shown previously to encode p40" (5) . As shown in Table 1 and Fig. 3 , rat cell lines expressing p40x as the only detectable viral protein increased the LTR function, thus strongly suggesting that p40x is a trans-acting factor that stimulates the promoter or enhancer function of the U3 sequence. p40x could mediate this function directly by binding to the LTR sequence or indirectly by modifying other cellular components. Thus, p40x would increase expression of the viral genome, stimulating replication of HTLV-I. Similarly, p40x might also act on a cellular regulatory sequence activating certain cellular genes which could be T-cell specific. These possible activations of cellular genes through viral protein p40X could be a mechanism in the early stages of ATL development.
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